3 B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting B-Cell Acute Lymphoblastic Leukemia Studies in Chicago

NCT05082519Recruiting

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

This study is for older children, adolescents, and young adults with B-cell Acute Lymphoblastic Leukemia (B-ALL). Higher amounts of body fat is associated with resistance to chemotherapy in patients w...

Chicago, ILPHASE2240 participantsEtan Orgel

View Study Details

NCT04150497Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

This is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The...

Chicago, ILPHASE152 participantsCellectis S.A.

View Study Details

NCT03595917Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

This research study is evaluating a drug called ABL001 taken in combination with dasatinib (Sprycel®) and prednisone (a steroid) as a possible treatment for B-cell Acute Lymphoblastic Leukemia that is...

Chicago, ILPHASE140 participantsMarlise Luskin, MD

View Study Details

About B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Chicago

B-cell acute lymphoblastic leukemia (B-ALL) is a fast-growing cancer of the B-type lymphocyte white blood cells. It is the most common childhood cancer but can also occur in adults. Treatment includes chemotherapy, targeted therapy, and CAR-T cell therapy.

There are currently 3 b-cell acute lymphoblastic leukemia clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 332 participants. Research is being sponsored by Etan Orgel, Cellectis S.A., Marlise Luskin, MD. Clinical trial participation is free and participants receive study-related medical care at no cost.

B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Chicago — FAQ

Are there b-cell acute lymphoblastic leukemia clinical trials in Chicago?

Yes, there are 3 b-cell acute lymphoblastic leukemia clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What b-cell acute lymphoblastic leukemia treatments are being tested?

The 3 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for b-cell acute lymphoblastic leukemia.

Data updated October 16, 2026 from ClinicalTrials.gov